← Back to headlines
H.C. Wainwright Sees No Direct Link Between Roche Miss and Olema's OPERA-02 Trial
H.C. Wainwright analysts believe that Roche's recent financial miss does not directly impact the outlook for Olema Pharmaceuticals' OPERA-02 trial.
10 Mar, 15:20 — 10 Mar, 15:20
Sources
Showing 1 of 1 sources
